HSP90 overexpression potentiates the B-cell receptor and fibroblast growth factor receptor survival signals in chronic lymphocytic leukemia cells

Chronic lymphocytic leukemia (CLL) is still an incurable disease despite aggressive chemotherapies including the B-cell receptor (BCR) targeted-inhibitors. Therefore, we assessed the expression status of key signal mediators of the BCR pathway in CLL cells. Indeed, we detected aberrantly elevated le...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmud, Hasan, Mendez, Mariana, Mukhopadhyay, Bedabrata, Holter-Chakrabarty, Jennifer, Ghosh, Asish K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275782/
https://www.ncbi.nlm.nih.gov/pubmed/32547702
http://dx.doi.org/10.18632/oncotarget.27409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275782/
https://www.ncbi.nlm.nih.gov/pubmed/32547702
http://dx.doi.org/10.18632/oncotarget.27409

Ejemplares similares